Document is current
Any future updates will be listed below
-
Authors
Lu, Chunxiu
Jin, Liang
Zhou, Huifen
Yang, Jiehong
Wan, Haitong
-
Funding
Funding for this research was provided by:
the biosafety laboratory of integrated Chinese and Western medicine at Zhejiang Chinese Medicine University (BSL20205713156)
Zhejiang Province Traditional Chinese Medicine Science and Technology project (2023ZF157)
the Research Project of Zhejiang Chinese Medical University (2021RCZXZK23)
the National Natural Science Foundation of China (81930111)
- License Information
-
More Information
Article History
Received: 18 October 2023
Revised: 27 November 2023
Accepted: 27 November 2023
First Online: 18 January 2024
Declarations
:
: The author reports no conflicts of interest in this work.
: The Hangzhou First People’s Hospital ethics committee reviewed and approved the CSR-EC strain in Hangzhou, China. We confirm that informed consent was obtained from the study participants. We confirm that the guidelines outlined in the Declaration of Helsinki were followed.
